BIASIDRAL 5mg / 6.25mg tablets medication leaflet

C07BB07 bisoprolol + hydrochlorothiazide • Cardiovascular system | Beta blocking agents and thiazides | Beta blocking agents, selective, and thiazides

The combination of bisoprolol and hydrochlorothiazide is used to treat hypertension. Bisoprolol is a beta-blocker that reduces heart rate and blood pressure, while hydrochlorothiazide is a diuretic that helps eliminate excess water and salt from the body, thereby reducing blood volume.

The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.

Common side effects include dizziness, fatigue, nausea, and dry mouth. In rare cases, more severe adverse effects such as excessive blood pressure reduction, electrolyte imbalances, or allergic reactions may occur.

This combination is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients with severe kidney failure or other chronic conditions should consult their doctor before starting treatment.

General data about BIASIDRAL 5mg / 6.25mg

Substance: bisoprolol + hydrochlorothiazide

Date of last drug list: 01-07-2013

Commercial code: W58469010

Concentration: 5mg / 6.25mg

Pharmaceutical form: tablets

Quantity: 500

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Concentrations available for bisoprolol + hydrochlorothiazide

10mg/6.25mg, 2.5mg/6.25mg, 5mg/6.25mg